Experimental gene therapy improves sight in patients with rare sight disorder
London: Doctors helped two men suffering from progressive blindness to help regain some of their vision with the help of an experimental gene therapy.
After undergoing treatment to correct a faulty gene, the men were able to read two to four more lines on an optician's sight chart, which was a significant improvement since the doctors treated them. One man got treated more than two years ago, the Guardian reported.
Choroideremia is an X-linked disorder, which means that it is caused by a faulty gene, called CHM, on the X chromosome.
A genetically modified virus is used in the experimental therapy to smuggle healthy copies of the CHM gene into light-sensitive cells in the retina, and supporting tissue called retinal pigment epithelium.
Surgeons injected 10bn modified virus particles behind the retinas of the first six patients in the trial.
The injected viruses then infect the eye cells, which uses the new CHM gene to treat the genetic disorder.
The study has been published in the journal The Lancet.
More from India
More from World
More from Sports
More from Entertaiment
- PM Narendra Modi pitches for 'Selfie with daughter' initiative
- Kejriwal knew Tomar possessed fake degree, says Yogendra Yadav
- Ajinkya Rahane to captain India on Zimbabwe tour; Dhoni, Kohli rested
- Need another agricultural revolution: PM Modi
- Monsoon's after-effects troubling everyday lives in cities
- India vs Zimbabwe: Ajinkya Rahane to lead; MS Dhoni, Virat Kohli rested
- Tihar Jail's security breached: Lt Governor Najeeb Jung orders probe, Centre seeks report
- MEA declines information on Lalit Modi's passport issue, draws flak
- Varun-Shraddha's `ABCD2` holds a firm grip at Box Office!
- School director beaten to death after two students found dead in Bihar